369 related articles for article (PubMed ID: 28466438)
1. A mechanistic cohort study evaluating cognitive impairment in women treated for breast cancer.
Vardy JL; Stouten-Kemperman MM; Pond G; Booth CM; Rourke SB; Dhillon HM; Dodd A; Crawley A; Tannock IF
Brain Imaging Behav; 2019 Feb; 13(1):15-26. PubMed ID: 28466438
[TBL] [Abstract][Full Text] [Related]
2. Perceived cognitive impairment in people with colorectal cancer who do and do not receive chemotherapy.
Dhillon HM; Tannock IF; Pond GR; Renton C; Rourke SB; Vardy JL
J Cancer Surviv; 2018 Apr; 12(2):178-185. PubMed ID: 29080061
[TBL] [Abstract][Full Text] [Related]
3. Cognitive dysfunction and symptom burden in women treated for breast cancer: a prospective behavioral and fMRI analysis.
Jung MS; Zhang M; Askren MK; Berman MG; Peltier S; Hayes DF; Therrien B; Reuter-Lorenz PA; Cimprich B
Brain Imaging Behav; 2017 Feb; 11(1):86-97. PubMed ID: 26809289
[TBL] [Abstract][Full Text] [Related]
4. Recovery from chemotherapy-induced white matter changes in young breast cancer survivors?
Billiet T; Emsell L; Vandenbulcke M; Peeters R; Christiaens D; Leemans A; Van Hecke W; Smeets A; Amant F; Sunaert S; Deprez S
Brain Imaging Behav; 2018 Feb; 12(1):64-77. PubMed ID: 28102529
[TBL] [Abstract][Full Text] [Related]
5. Evaluating cognitive complaints in breast cancer survivors with the FACT-Cog and quantitative electroencephalography.
Van Dyk K; Hunter AM; Ercoli L; Petersen L; Leuchter AF; Ganz PA
Breast Cancer Res Treat; 2017 Nov; 166(1):157-166. PubMed ID: 28707203
[TBL] [Abstract][Full Text] [Related]
6. A randomised controlled trial evaluating two cognitive rehabilitation approaches for cancer survivors with perceived cognitive impairment.
Vardy JL; Pond GR; Bell ML; Renton C; Dixon A; Dhillon HM
J Cancer Surviv; 2023 Dec; 17(6):1583-1595. PubMed ID: 36241767
[TBL] [Abstract][Full Text] [Related]
7. Objective-subjective disparity in cancer-related cognitive impairment: does the use of change measures help reconcile the difference?
O'Farrell E; Smith A; Collins B
Psychooncology; 2017 Oct; 26(10):1667-1674. PubMed ID: 27278814
[TBL] [Abstract][Full Text] [Related]
8. The Developmental Trajectory of Cancer-Related Cognitive Impairment in Breast Cancer Patients: A Systematic Review of Longitudinal Neuroimaging Studies.
Sousa H; Almeida S; Bessa J; Pereira MG
Neuropsychol Rev; 2020 Sep; 30(3):287-309. PubMed ID: 32607817
[TBL] [Abstract][Full Text] [Related]
9. Testing a novel account of the dissociation between self-reported memory problems and memory performance in chemotherapy-treated breast cancer survivors.
Paquet L; Verma S; Collins B; Chinneck A; Bedard M; Song X
Psychooncology; 2018 Jan; 27(1):171-177. PubMed ID: 28129471
[TBL] [Abstract][Full Text] [Related]
10. Perceived cognitive function in breast cancer survivors: evaluating relationships with objective cognitive performance and other symptoms using the functional assessment of cancer therapy-cognitive function instrument.
Von Ah D; Tallman EF
J Pain Symptom Manage; 2015 Apr; 49(4):697-706. PubMed ID: 25240787
[TBL] [Abstract][Full Text] [Related]
11. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.
Ganz PA; Kwan L; Castellon SA; Oppenheim A; Bower JE; Silverman DH; Cole SW; Irwin MR; Ancoli-Israel S; Belin TR
J Natl Cancer Inst; 2013 Jun; 105(11):791-801. PubMed ID: 23606729
[TBL] [Abstract][Full Text] [Related]
12. Cancer treatment effects on cognition and depression: The moderating role of physical activity.
Bedillion MF; Ansell EB; Thomas GA
Breast; 2019 Apr; 44():73-80. PubMed ID: 30685529
[TBL] [Abstract][Full Text] [Related]
13. Inflammation markers and cognitive performance in breast cancer survivors 20 years after completion of chemotherapy: a cohort study.
van der Willik KD; Koppelmans V; Hauptmann M; Compter A; Ikram MA; Schagen SB
Breast Cancer Res; 2018 Nov; 20(1):135. PubMed ID: 30442190
[TBL] [Abstract][Full Text] [Related]
14. Brain structure and function in patients with ovarian cancer treated with first-line chemotherapy: a pilot study.
Correa DD; Root JC; Kryza-Lacombe M; Mehta M; Karimi S; Hensley ML; Relkin N
Brain Imaging Behav; 2017 Dec; 11(6):1652-1663. PubMed ID: 27766586
[TBL] [Abstract][Full Text] [Related]
15. Age-dependent brain volume and neuropsychological changes after chemotherapy in breast cancer patients.
Blommaert J; Schroyen G; Vandenbulcke M; Radwan A; Smeets A; Peeters R; Sleurs C; Neven P; Wildiers H; Amant F; Sunaert S; Deprez S
Hum Brain Mapp; 2019 Dec; 40(17):4994-5010. PubMed ID: 31436005
[TBL] [Abstract][Full Text] [Related]
16. Connectome analysis of brain functional network alterations in breast cancer survivors with and without chemotherapy.
Chen VC; Lin KY; Tsai YH; Weng JC
PLoS One; 2020; 15(5):e0232548. PubMed ID: 32365133
[TBL] [Abstract][Full Text] [Related]
17. Associating persistent self-reported cognitive decline with neurocognitive decline in older breast cancer survivors using machine learning: The Thinking and Living with Cancer study.
Van Dyk K; Ahn J; Zhou X; Zhai W; Ahles TA; Bethea TN; Carroll JE; Cohen HJ; Dilawari AA; Graham D; Jacobsen PB; Jim H; McDonald BC; Nakamura ZM; Patel SK; Rentscher KE; Saykin AJ; Small BJ; Mandelblatt JS; Root JC
J Geriatr Oncol; 2022 Nov; 13(8):1132-1140. PubMed ID: 36030173
[TBL] [Abstract][Full Text] [Related]
18. Effect of aerobic exercise on cancer-associated cognitive impairment: A proof-of-concept RCT.
Campbell KL; Kam JWY; Neil-Sztramko SE; Liu Ambrose T; Handy TC; Lim HJ; Hayden S; Hsu L; Kirkham AA; Gotay CC; McKenzie DC; Boyd LA
Psychooncology; 2018 Jan; 27(1):53-60. PubMed ID: 28075038
[TBL] [Abstract][Full Text] [Related]
19. Cognitive Function in Patients With Colorectal Cancer Who Do and Do Not Receive Chemotherapy: A Prospective, Longitudinal, Controlled Study.
Vardy JL; Dhillon HM; Pond GR; Rourke SB; Bekele T; Renton C; Dodd A; Zhang H; Beale P; Clarke S; Tannock IF
J Clin Oncol; 2015 Dec; 33(34):4085-92. PubMed ID: 26527785
[TBL] [Abstract][Full Text] [Related]
20. Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study.
Janelsins MC; Heckler CE; Peppone LJ; Kamen C; Mustian KM; Mohile SG; Magnuson A; Kleckner IR; Guido JJ; Young KL; Conlin AK; Weiselberg LR; Mitchell JW; Ambrosone CA; Ahles TA; Morrow GR
J Clin Oncol; 2017 Feb; 35(5):506-514. PubMed ID: 28029304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
